• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
'Press Releases' Section describes most distant clients with latest product-specific, company-related updates is a key value addition to our members because they can use this platform as the easiest, earlier and the most effective means to get noticed quickly. Our press release programs work hand in hand with our SEO programs to provide a rock solid positioning in all major search engines so as to contemplate the visibility of your message for Worldwide Healthcare industry.

To learn more on how to reach a suitable target audience by distributing / publicizing your content(the latest happenings about your company) as in 'Press Releases' through 'Global Healthcare Technology', This email address is being protected from spambots. You need JavaScript enabled to view it.
Quanta Dialysis System

Quanta™ Receives FDA 510(k) Clearance for Expanded Indication of Continuous Renal Replacement Therapies

Quanta Dialysis Technologies®, a medical technology company committed to making kidney care more accessible,announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for an expanded indication of the Quanta Dialysis System, a compact and easy-to-use hemodialysis device.

Read more →
XRP Healthcare and Spiritus Medical

XRP Healthcare and Spiritus Medical Partner to Revolutionize Healthcare in Africa

XRP Healthcare and Spiritus Medical is thrilled to announce their strategic collaboration, set to transform the healthcare landscape in Africa. This groundbreaking partnership aims to bring cutting-edge medical technology to the region,starting with the integration of the SPIRITUS VITALITY Ventilator into newly acquired medical facilities in East Africa, with Uganda as the initial focus.

Read more →

GORE® VIAFORT Vascular Stent iliofemoral Study

W. L. Gore & Associates (Gore) has announced that the first U.S. patient has been enrolled in a prospective, non-randomized, multicenter, single-arm study with five-year follow-up (NCT05489588) to evaluate the investigational GORE® VIAFORT Vascular Stent for the treatment of symptomatic iliofemoral venous obstruction.

Read more →